(i.e., silver,14 palladium,15 and gold complexes).16 More-
over, cyclic amino acids, such as dehydroprolines, had
been prepared respectively by Pd- and Ag-catalyzed
5-endo-dig cyclization of N-Ts- and Boc-protected propar-
gylglycine analogs.17,18
To study the cyclization, aza-propargylglycinyl dipep-
tide 1 was used and prepared by chemoselective alkylation
of benzhydrylidene aza-glycinyl-D-phenylalanine tert-bu-
tyl ester (5) with propargyl bromide (Schemes 1 and 2).19
Attempted 5-exo-dig cyclization of azadipeptide 1 using
homogeoneous gold catalysis [(t-Bu)2(o-biphenyl)PAuCl
(5 mol %) and AgOTf (5 mol %)] failed, likely because the
urea nitrogen was insufficiently electron-deficient.
Scheme 1. N-Amino-imidazolin-2-one synthesis
Figure 1. N-Amino-imidazolin-2-one turn mimic conception.
receptor antagonists,6,7 antioxidants,8 and unnatural base
pairs.9 To the best of our knowledge, however, the synthe-
sis and biological evaluation of N-amino-imidazolin-2-
ones had not been explored.
Previously, the submonomer approach for azapeptide
synthesis surmounted issues of hydrazine chemistry to give
access to side chains inaccessible by traditional methodology,
including propargyl, allyl, and (hetero)aryl moieties.10,11 The
aza-propargylglycine side chain was later reacted in copper-
catalyzed 1,3-dipolar cycloadditions to make aza-1,2,3-
triazole-3-alaninyl peptide mimics.12 Aza-propargylglycina-
mides have now been explored in 5-exo-dig cyclizations to
access N-amino-imidazolin-2-one peptidomimetics, as well
as in Sonogashira cross-coupling reactions prior to cycliza-
tion to provide their 4-arylmethyl analogues, which may
mimic phenylalanine and tryptophan residues.
Imidazolin-2-ones and imidazolidin-2-ones have been
respectively prepared from propargylic and allylic ureas by
base-promoted 5-exo-dig cyclizations.13 Annulation has
typically necessitated an electron-deficient urea nitrogen
and activation of the π-system using transition metal salts
N-Amino-imidazolin-2-one 2 was, however, obtained in
81% yield, by adding 2.5 equiv of NaH to the mixture
containing 1 and the cationic gold complex formed in situ
in acetonitrile for 2 h. The impact of goldcatalysis was later
deemednegligible, because2 was producedin84% yield on
reaction of 1 with 2.5 equiv of NaH in acetonitrile without
a catalyst (Scheme 1). From the 5-exo-dig cyclization, an
exocyclic double bond was first produced and migrated
inside the ring to furnish the thermodynamically more
stable N-amino-imidazolin-2-one 3. Among the solvents
studied, acetonitrile proved the best (see Supporting In-
formation (SI)). Excess NaH was necessary for high yields.
To study the effect of N-amino-imidazolin-2-one on
peptide conformation, model 10 was synthesized and
examined by X-ray crystallography and NMR spectro-
scopy (Scheme 2). Benzhydrylidene aza-glycinyl-D-pheny-
lalanine isopropyl amide 7 was made from 5 by tert-butyl
ester cleavage in a 1:1 v/v mixture of TFA/DCM
and coupling to isopropylamine by way of a mixed
anhydride.20 Alkylation of semicarbazone 7 with
propargylbromide19,20 gave aza-propargylglycinamide 8
in 71% yield without detectable racemization; however,
(8) (a) Smith, R. C.; Reeves, J. C. Biochem. Pharmacol. 1987, 36,
1457. (b) Watanabe, K.; Morinaka, Y.; Hayashi, Y.; Shinoda, M.; Nishi,
H.; Fukushima, N.; Watanabe, T.; Ishibashi, A.; Yuki, S.; Tanaka, M.
Bioorg. Med. Chem. Lett. 2008, 18, 1478–1483.
(9) (a) Hirao, I.; Kimoto, M.; Harada, Y.; Fujiwara, T.; Sato, A.;
Yokoyama, S. Nucleic Acids Res. Suppl. 2002, 2, 37–38. (b) Hirao, I.;
Harada, Y.; Kimoto, M.; Mitsui, T.; Fujiwara, T.; Yokoyama, S. J. Am.
Chem. Soc. 2004, 126, 13298–13305.
(10) (a) Sabatino, D.; Proulx, C.; Klocek, S.; Bourguet, C. B.;
Boeglin, D.; Ong, H.; Lubell, W. D. Org. Lett. 2009, 11, 3650. (b)
Sabatino, D.; Proulx, C.; Pohankova, P.; Ong, H.; Lubell, W. D. J. Am.
Chem. Soc. 2011, 133, 12493–12506.
(11) Proulx, C.; Lubell, W. D. Org. Lett. 2010, 12, 2916–2919.
(12) Proulx, C.; Lubell, W. D. J. Org. Chem. 2010, 75, 5385–5387.
(13) (a) Chiu, S.-K.; Keifer, L.; Timberlake, J. W. J. Med. Chem.
1979, 22, 746–748. (b) Easton, N. R.; Cassady, D. R.; Dillard, R. D.
J. Org. Chem. 1964, 29, 1851–1855.
(17) Wolf, L. B.; Tjen, K. C. M. F.; ten Brick, H. T.; Blaauw, R. H.;
Hiemstra, H.; Schoemaker, H. E.; Rutjes, F. P. J. T. Adv. Synth. Catal.
2002, 344, 70–83.
(18) Van Esseveldt, B. C. J.; Vervoort, P. W. H.; van Delft, F. L.;
Rutjes, F. P. J. T. J. Org. Chem. 2005, 70, 1791–1795.
´
(19) Garcıa-Ramos, Y.; Proulx, C.; Lubell, W. D. Can. J. Chem.
(14) Peshkov, V. A.; Pereshivko, O. P.; Sharma, S.; Meganathan, T.;
Parmar, V. S.; Ermolat’ev, D. S.; Van der Eycken, E. V. J. Org. Chem.
2011, 76, 5867–5872.
(15) (a) Lei, A.; Lu, X. Org. Lett. 2000, 2 (17), 2699–2702. (b) Fritz,
J. A.; Wolfe, J. P. Tetrahedron. 2008, 64, 6838–6852.
(16) (a) Zhang, G.; Luo, Y.; Wang, Y.; Zhang, L. Angew. Chem., Int. Ed.
2012, 90, in press.
(20) Bourguet, C. B.; Proulx, C.; Klocek, S.; Sabatino, D.; Lubell,
2011, 50, 1–6. (b) Verniest, G.; Padwa, A. Org. Lett. 2008, 10, 4379–4382.
W. D. J. Pept. Sci. 2010, 16, 284–296.
Org. Lett., Vol. 14, No. 17, 2012
4553